It’s no secret that digital technologies are playing a significant role when it comes to shaping the next era of healthcare.
This was the subject of a recent pharmaphorum webinar, sponsored by Healthware International, where Healthware CEO Roberto Ascione and Politecnico di Milano Professor Emanuele Lettieri laid out plans for a new executive education programme in digital health innovation.
“There is no way we can find enough people that are really skilled about these new modalities, these new interactions, and way of doing things,” explained Ascione. “
Creating a hybrid learning experience Of course, when creating a programme for high-level figures across life sciences, it’s vital to understand and tailor the learning experience to suit the lives and responsibilities of participants.
Through the design of the programme, both Ascione and Lettieri believe that participants will be introduced to a comprehensive range of topics – ideas they claim that every person working in life sciences should be aware of.
While most large organizations are hedging their bets by sticking a figurative “toe” into the Metaverse, CVS has it’s whole head in there. Unlike others, the healthcare giant appears to be preparing to offer producs and services, including telehealth, in a virtual world.
Those virtual goods could include health products, prescription drug products, and beauty products. In addition, CVS is also trying to bring the health services it provides in its in-store clinics and its telehealth platform to the Metaverse, according to CNBC.
Metaverse expected to impact 25% of the population in the next five years.
According to PharmExec.com; the Metaverse “is poised to transform how we interact with brands and connect with others. A new report by research firm Gartner1 predicts that by 2026, 25% of people will spend at least one hour per day in the metaverse for work, shopping, education, social and/or entertainment. It’s also expected that 30% of the organizations in the world will have products and services ready for the metaverse by 2026.”
A 2021 Facts and Factors market research report estimates that VR in healthcare will reach a value of approximately $40.98 billion USD by 2026, up from only $2.70 billion in 2020. However, to unlock its full potential, the industry must first overcome a few initial roadblocks to adoption.